Clearly it is a difficult challenge, but an in-depth understanding of the molecular mechanisms involved in DAB2IP inactivation may enable the development of ad hoc strategies to manipulate its expression and function, that could have a relevant impact for cancer therapy. The gene discussed is DAB2IP; the disease is cancer.